> Research summary—not medical advice. This page synthesizes published research on a mechanism-level intervention. It is not a clinical recommendation.
Consult a qualified healthcare provider before making any changes to diet, supplementation, or treatment.
Contents
1. Overview2. Mechanism of Action3. Dosage and Administration4. Monitoring5. Contraindications and Risks6. ConnectionsOverview#
Vitamin D supplementation provides the secosteroid hormone precursor that activates the vitamin D receptor (VDR)—a nuclear receptor expressed in virtually every immune cell, enterocyte, and neuron.
Vitamin D deficiency is pandemic (estimated 1 billion people worldwide) and intersects with autoimmune, neurological, metabolic, and gastrointestinal diseases through immunomodulatory, barrier-protective, and neuroendocrine pathways.
> Clinical disclaimer: Vitamin D supplementation should be guided by measured 25(OH)D levels. Target 40-60 ng/mL (100-150 nmol/L) for autoimmune and neurological conditions. Doses above 4000 IU/day require monitoring to avoid hypercalcemia.
Vitamin D is fat-soluble and accumulates; toxicity is rare below 10,000 IU/day but possible with impaired renal function. All dosing decisions require clinical supervision.
Mechanism of Action#
Vitamin D operates through three primary pathways. Immune modulation: VDR activation on T cells promotes Treg differentiation (IL-10, TGF-beta), suppresses Th17 polarization (IL-17, IL-22), and induces tolerogenic dendritic cells. This rebalances the Th17/Treg axis disrupted in autoimmune diseases.
Barrier integrity: VDR in intestinal epithelium upregulates tight junction proteins (claudin-2, occludin, ZO-1) and antimicrobial peptides (cathelicidin LL-37, beta-defensin 2). Deficiency increases intestinal permeability.
Neuroendocrine regulation: VDR in hippocampal and prefrontal neurons activates TPH2 (tryptophan hydroxylase 2) transcription, directly increasing brain serotonin synthesis. Also upregulates BDNF and modulates HPA axis reactivity.
Dosage and Administration#
| Condition | Dose | Form | Duration | Notes |
|---|---|---|---|---|
| Multiple Sclerosis | 4000 IU/day (up to 7000 IU/day in trials) | Cholecalciferol (D3) | Ongoing | Target 25(OH)D 40-60 ng/mL; adjunct to DMT |
| Hashimoto's Thyroiditis | 2000-4000 IU/day | Cholecalciferol (D3) | Ongoing | Combine with Selenium Supplementation 200 ug/day |
| Inflammatory Bowel Disease (IBD) | 2000-4000 IU/day | Cholecalciferol (D3) | Ongoing | Higher doses during flares; monitor absorption |
| Depression | 2000-4000 IU/day | Cholecalciferol (D3) | 8-12 weeks minimum | Best evidence in documented deficiency |
| Polycystic Ovary Syndrome | 2000-4000 IU/day | Cholecalciferol (D3) | 12+ weeks | Combine with Probiotics (General) for synergistic metabolic effect |
General notes. Cholecalciferol (D3) is preferred over ergocalciferol (D2) for efficacy and half-life. Take with a fat-containing meal to optimize absorption.
Loading doses (50,000 IU weekly for 8 weeks) appropriate for severe deficiency (<20 ng/mL).
Maintenance range: 2000-4000 IU/day for most adults.
Monitoring#
- 25(OH)D (calcidiol): The standard monitoring biomarker. Measure at baseline, 8-12 weeks, then every 6 months.
- Deficiency: <20 ng/mL (<50 nmol/L)
- Insufficiency: 20-30 ng/mL (50-75 nmol/L)
- Optimal for autoimmune/neurological: 40-60 ng/mL (100-150 nmol/L)
- Toxicity concern: >100 ng/mL (>250 nmol/L)
- Calcium (serum): Check at baseline and if dosing >4000 IU/day; hypercalcemia is the primary toxicity
- PTH (parathyroid hormone): Elevated PTH with low 25(OH)D confirms functional deficiency
- 1,25(OH)2D (calcitriol): NOT a routine monitoring marker (short half-life, tightly regulated); useful only in granulomatous disease or renal failure
Contraindications and Risks#
Hypercalcemia: Primary toxicity risk; more likely with granulomatous diseases (sarcoidosis, tuberculosis) where unregulated 1-alpha-hydroxylase converts 25(OH)D to active calcitriol. Renal impairment: Reduced calcitriol clearance increases hypercalcemia risk; dose adjustment required. Hyperphosphatemia: May compound in CKD.
Drug interactions: Corticosteroids reduce vitamin D efficacy; thiazide diuretics increase calcium retention. Fat malabsorption: IBD, celiac, or short-bowel patients may require higher doses or intramuscular administration.
Connections#
Entities: Selenium, Zinc, Iron
Concepts: Immune Balance, Intestinal Permeability, Gut-Brain Axis, Neuroinflammation, Dysbiosis
Related interventions: Selenium Supplementation (synergistic in Hashimoto's), Probiotics (General) (synergistic in PCOS), Zinc Supplementation (complementary immune support)
Signatures: Multiple Sclerosis, Hashimoto's Thyroiditis, Inflammatory Bowel Disease (IBD), Depression, Polycystic Ovary Syndrome
> Educational content, not medical advice. This page describes mechanisms by which the intervention interacts with the microbiome and metal ecology. It is not a treatment recommendation.
Clinical decisions about any intervention should be made with a qualified healthcare practitioner who knows your individual history.
Article network
Mentioned here 16
Pages linking here 5
Connect the evidence
Publicly readable discussion by ORCID-authenticated researchers. Questions, interpretation, methods, corrections, and new evidence stay attached to this record.
No discussion yet. Start with a precise question or a source-backed observation.
Activity and accepted changes
Accepted researcher context, editorial status, public discussion, and upstream Git revisions are shown together. Pending, declined, and withdrawn proposals remain private.
- published revision
massive wiki expansion: 149 stubs fixed, 100+ new pages, Rule 15 scan, keystone papers
WikiBiome Deploy Bot · +21 −21
Inspect exact Git diff ↗ - published revision
pre-overnight checkpoint 2026-04-18
WikiBiome Deploy Bot · +2 −0
Inspect exact Git diff ↗ - published revision
Adversarial audit fixes: confidence downgrades, disclaimers, STOP safety, entity cleanup
WikiBiome Deploy Bot · +7 −0
Inspect exact Git diff ↗ - published revision
WikiBiome v2 migration: signature pages + safety fixes + gap analysis
WikiBiome Deploy Bot · +129 −0
Inspect exact Git diff ↗